Cue Biopharma, Inc. (CUE) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $26 million, Cue Biopharma, Inc. is a micro-cap company. The stock currently trades at $0.29, up 2.82% today, with a 52-week range of $0.23–$1.31.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.72 | $-0.72 | +35.1% | |
| 2023 | $-1.11 | $-1.11 | +25.5% | |
| 2022 | $-1.49 | $-1.49 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0000950170-25-047677 | SEC ↗ |
| 2023-12-31 | 2024-03-28 | 0000950170-24-038059 | SEC ↗ |
| 2022-12-31 | 2023-03-21 | 0000950170-23-008927 | SEC ↗ |
| 2021-12-31 | 2022-03-16 | 0000950170-22-003969 | SEC ↗ |
| 2020-12-31 | 2021-03-09 | 0001564590-21-011777 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001564590-20-010212 | SEC ↗ |
| 2018-12-31 | 2019-03-14 | 0001564590-19-007832 | SEC ↗ |
| 2017-12-31 | 2018-03-29 | 0001144204-18-017978 | SEC ↗ |